BCAT1
BCAT1 (branched chain amino acid transaminase 1, also known as BCATc or BCT1) is the cytosolic aminotransferase that catalyses the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine and valine. It is a pyridoxal-phosphate-dependent enzyme of the class-IV aminotransferase family. Browse Assay Genie's current range of BCAT1 research reagents below, or read on for the biology behind the target.
BCAT1 catalyses the first step in the breakdown of the essential branched chain amino acids leucine, isoleucine and valine. The reaction is a reversible transamination in which branched-chain alpha-keto acids are interconverted with branched-chain L-amino acids, which are essential for cell growth. The enzyme belongs to the class-IV pyridoxal-phosphate-dependent aminotransferase family, and its EC number is 2.6.1.42.
The BCAT1 gene encodes the cytosolic form of branched-chain amino acid transaminase, and the protein is annotated to the cytoplasm. A separate gene encodes a mitochondrial form of the enzyme, BCAT2, so the cytosolic and mitochondrial isoenzymes are products of distinct genes. Alternatively spliced transcript variants have been described for BCAT1. The mouse and rat orthologues are both named Bcat1, which allows comparative work in common model organisms.
HGNC places the gene in the branched chain amino acid transaminase family. Earlier names include branched chain aminotransferase 1, cytosolic, and the aliases BCATc and BCT1 are still found in the literature. Two clinical disorders have been attributed to defective branched-chain amino acid transamination: hypervalinemia and hyperleucine-isoleucinemia. Because the cytosolic and mitochondrial enzymes are encoded by different genes, mutations in either gene may contribute to these disorders. Researchers studying branched-chain amino acid handling can use a BCAT1 antibody, a BCAT1 ELISA kit or recombinant BCAT1 protein to examine the enzyme.
BCAT1 catalyses the first reaction in leucine, isoleucine and valine catabolism, making it a central enzyme for studying branched chain amino acid metabolism.
The enzyme interconverts branched-chain alpha-keto acids and branched-chain L-amino acids that are essential for cell growth.
Defective branched-chain amino acid transamination is linked to hypervalinemia and hyperleucine-isoleucinemia, and BCAT1 or BCAT2 variants may contribute.
Distinct genes encode the cytosolic and mitochondrial transaminases, so BCAT1 is useful for comparing compartment-specific branched-chain amino acid metabolism.
BCAT1 is a cytosolic aminotransferase that catalyses the first reaction in the catabolism of leucine, isoleucine and valine. It carries out reversible transamination between branched-chain alpha-keto acids and branched-chain L-amino acids, which are essential for cell growth.
BCAT1 is also called BCATc and BCT1, and was formerly named branched chain aminotransferase 1, cytosolic. UniProt lists it as branched-chain-amino-acid aminotransferase, cytosolic. NCBI reports that alternatively spliced transcript variants have been described for the gene.
Defects in branched-chain amino acid transamination are linked to hypervalinemia and hyperleucine-isoleucinemia, and mutations in BCAT1 or the mitochondrial gene may contribute. Mouse and rat both have a Bcat1 orthologue; check the datasheet of any product for its validated reactivity.
The mitochondrial branched-chain aminotransferase encoded by a separate gene, with related products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P54687; product specifications from Assay Genie datasheets.